Tibet Zheng Qi Tibetan Medicine Co., Ltd. (hereinafter referred to as Zheng Qi Tibetan Medicine, stock code: 002287) is the largest Tibetan medicine manufacturer in China, mainly engaged in research and development, production and sales of new Tibetan medicines. At present, it has 7 wholly-owned and holding subsidiaries, including GMP pharmaceutical factory and GSP listed company, with 69 drug approval numbers. Covering cardiovascular and cerebrovascular diseases, respiratory system, digestive system, urogenital system, nervous system, musculoskeletal system, gynecological diseases and other fields, a series of external analgesic drugs represented by Zheng Qi Xiaotong Plaster have been selling well for many years, with extremely high clinical efficiency. The utilization rate in the Mainland is nearly 200 million, ranking first in the national external analgesic drug market for six consecutive years, ranking first in the first OTC product list of traditional Chinese medicine surgery, and being listed as a key brand of over-the-counter drugs.